WELCOME TO

CHICAGO CLINICAL RESEARCH INSTITUTE

Multi-specialty Group Practice And Dedicated Research Site Conducting Phase I To Phase Iv Clinical Trials. 

ABOUT US

Founded in 2008 Chicago Clinical Research Institute, Inc. (CCRII) is a multi-specialty dedicated research facility conducting phase II to phase IV clinical trials. CCRII has a combined 50 years of clinical research experience and has conducted more than 250 clinical research trials in the therapeutic areas of Cardiovascular Disease, Chronic Kidney Disease, Diabetes Mellitus Type I & II, Diabetic Foot Ulcer (DFU), Gynecology, Hyperlipidemia, Hypertension, Lower back pain, Male Health, Neurology/Headache, Neuropathy, Oncology, Ophthalmology, Opioid Use Disorder (OUD), Osteoarthritis, Pain Management, and Rheumatoid Arthritis.

OUR RESEARCH FACILITY

We are a Phase I-IV research facility and we have conducted over 350 research protocols to date. Through a dedicated and experienced staff, we provide the utmost quality of care to all of our research participants.

  • Dedicated monitoring rooms

  • Dedicated IP Storage room with double-locked 24X7 video surveillance

  • AED and Emergency Equipment

  • Free Validated Parking

  • Partnership with various entities for in patient studies

  • Exam rooms with calibrated EKG/vitals sign equipment

  • Laboratory with a refrigerated centrifuge

  • -20 degree and -70 degree freezer for PK samples

  • Onsite infusions

  • Large waiting area for patients

50+

Yeaers

Experienced

Meet Our Clinical Expert

Dr. Levinson MD, FACP, FACR

Expertise: Rheumatology

Dr. Dennis diagnoses and treat diseases that affect the joints, soft tissue and connective tissues. Many of these conditions result from autoimmune disorders, including rheumatoid arthritis, scleroderma and systemic lupus erythematosus.

Our principal investigators Dr. Ahmed, dr.kassar, Dr.Beard, dr.alvi, dr. lassiter, dr.james and Dr. Levinson have completed more than 350 clinical trials, phase I, II, III and IV in many therapeutic areas such as Cardiovascular Disease, Chronic Kidney Disease, Diabetes Mellitus Type I & II, Diabetic Foot Ulcer (DFU), Gynecology, Hyperlipidemia, Hypertension, Lower back pain, Male Health, Neurology/Headache, Neuropathy, Oncology, Ophthalmology, Opioid Use Disorder (OUD), Osteoarthritis, NASH, Pain Management, and Rheumatoid Arthritis.

our physicians have together published more than 81 publications in many reputable journals, such as new england, jama, lanceT. Below are a few links to their publications.

Our Global Presence from USA to JAPAN

  • Abbott

  • AbbVie

  • Amgen

  • Astellas Pharma

  • AstraZeneca

  • Bayer

  • BioDelivery Sciences Intl.

  • Biogen

  • Boehringer Ingelheim

  • Bristol-Myers Squibb

  • Daiichi Sankyo Company

  • Eli Lilly and Company

  • Esperion Therapeutics

  • Genentech

  • Gilead

  • GlaskoSmithKline

  • Hisamitsu Pharmaceutical Co.

  • Hoffmann-LaRoche

  • Janssen

  • Johnson and Johnson

  • Kowa Pharmaceuticals America

  • MannKind Corporation

  • Merck

  • Mylan

  • Novartis

  • Novo Nordisk

  • Orexigen Therapeutics

  • Pfizer

  • Purdue Pharma

  • Quantum Genomics

  • Regeneron Pharmaceuticals

  • Roche

  • Samumed

  • Sanofi

  • Semnur

  • Sucampo Pharmaceuticals

  • Takeda

  • Teva Pharmaceutical Industries

  • The Medicines Company

  • Theracos

  • Invidior

  • Biolytic

  • Argenx

  • Crystalys Therapeutics

  • Sparrow

compounds that our physicians have worked on as Principal Investigators.

  • Adalimumab

  • ALN-PCSSC

  • Alogliptin

  • Alosteron

  • Amlodipine

  • Androgel

  • ASP1941

  • Atrasentan

  • Bardoxolone Methyl

  • Bexagliflizin

  • BI 695500

  • BI 695501

  • BMP-7

  • Bococizumab

  • Calcifediol

  • Canagliflozin Choline

  • Fenofibrate

  • Clonidine HCl

  • Tpical Gel 0.1%

  • CTP-499

  • Dapagliflozin

  • Darbepoetin

  • Alfa Diacerein

  • Diacerein

  • Dutogliptin

  • Elagolix

  • Epotein Alfa

  • Empagliflozin

  • Etanercept/Enbr

  • Evolocumab

  • Exenatide

  • Fasinumab

  • Fulranumab

  • GSK189075

  • GSK3196165

  • HKT-500

  • Hydrocodone

  • Extended- release Insulin

  • Detemir Insulin

  • JTT-851

  • Linaclotide

  • Linagliptin el

  • Liraglutide

  • Lixisenatide

  • Lubiprostone

  • MOA-728

  • Mylan Insulin Glargine

  • Naltrexone SR/Bupropion SR

  • Nebivolol

  • Oravescent

  • Fentanyl Citrate

  • Oxycodone/Nal oxone

  • Peginesatide

  • Pemafibrate

  • Perindopril

  • Pioglitazone HCl

  • PT003

  • PT009

  • PT010

  • QGC001

  • Regadenoson

  • Repaglinide/Metf ormin

  • Rituximab

  • RO6807952

  • Roxadustat

  • SAR425899

  • Semaglutide

  • SM04690

  • Sotagliflozin

  • TAK-875

  • Tanezumab

  • Tapentadol

  • Ticagrelor

  • Tocilizumab

  • Tujeo (Insuline Glargine 300U/L)

  • Valsartan

  • Insulin Glargine/Lixisen atide (LixiLan)

Stay Updated with
Our Newest Insights

The Art of Blending Personal Growth
Methods for Harmonizing Objectives
Helpful Advice for Reaching
The Art of Blending Personal
Image

Address

611 W. Roosevelt Rd., Chicago, IL 60607, USA. | 1229 Ogden Ave. Downers Grove, IL 60515, USA

Image

Call Us

(312) 823 - 6800

Image

Send us a Mail

Image

Opening Hours

Mon-Fri: 8:00 AM - 7:00 PM

Fri: 9:00 AM - 2:00 PM

611 W Roosevelt Rd, Chicago, IL 60607, USA

Get in Touch with us

We’re here to help anytime

Image

Opening Time

Mon -Sat: 7:00 - 17:00